SCHEMBL15569374

SCHEMBL15569374

C=CC=CC1(C)CCN(C(=O)OCCCC)CC1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
POLB P06746 2/20 0.50
SMN1; SMN2 Q16637 2/20 0.50
LMNA P02545 1/20 0.50
TSHR P16473 2/20 0.41
HPGD P15428 1/20 0.41
OPRD1 P41143 1/20 0.39
OPRK1 P41145 1/20 0.39
HRH2 P25021 5/20 0.37
HRH1 P35367 5/20 0.37
ATM Q13315 1/20 0.36
ALDH1A1 P00352 3/20 0.34
L3MBTL1 Q9Y468 1/20 0.34
P2RY12 Q9H244 1/20 0.33
CHRM2 P08172 1/20 0.33
CHRM1 P11229 1/20 0.33
KDM4E B2RXH2 1/20 0.33
TDP1 Q9NUW8 1/20 0.33
GBA2 Q9HCG7 1/20 0.33
HCAR2 Q8TDS4 1/20 0.33
HTT P42858 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15569373 1.00 POLB (0.50) POLBSMN1; SMN2LMNATSHRHPGD
SCHEMBL30135752 0.83 POLB (0.55) POLBSMN1; SMN2LMNATSHRHPGD
SCHEMBL29923989 0.78 SMN1; SMN2 (0.49) POLBSMN1; SMN2LMNATSHRHPGD
SCHEMBL27842859 0.77 POLB (0.58) POLBSMN1; SMN2LMNATSHRHPGD
SCHEMBL15476025 0.76 USP2 (0.44) SMN1; SMN2LMNATSHRHPGDATM
SCHEMBL15476024 0.76 USP2 (0.44) SMN1; SMN2LMNATSHRHPGDATM
SCHEMBL346648 0.76 SMN1; SMN2 (0.56) POLBSMN1; SMN2LMNATSHRHPGD
SCHEMBL30136060 0.76 POLB (0.56) POLBSMN1; SMN2LMNATSHRHPGD
SCHEMBL9405372 0.75 POLB (0.73) POLBSMN1; SMN2LMNATSHRHPGD
SCHEMBL16150742 0.75 TET3 (0.30)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2970301-A1 INHIBITORS OF HUMAN IMMUNODEFICIENCY VIRUS REPLICATION Bristol-Myers Squibb Company (US) 2016-01-20 EP disclosed
EP-2888266-A1 INHIBITORS OF HUMAN IMMUNODEFICIENCY VIRUS REPLICATION Bristol-Myers Squibb Company (US) 2015-07-01 EP disclosed
WO-2014164428-A1 INHIBITORS OF HUMAN IMMUNODEFICIENCY VIRUS REPLICATION BRISTOL-MYERS SQUIBB COMPANY (US) 2014-10-09 WO disclosed
WO-2014028384-A1 INHIBITORS OF HUMAN IMMUNODEFICIENCY VIRUS REPLICATION BRISTOL-MYERS SQUIBB COMPANY (US) 2014-02-20 WO disclosed